K Number
K050027
Date Cleared
2005-01-27

(21 days)

Product Code
Regulation Number
876.1500
Reference & Predicate Devices
Predicate For
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
Intended Use

The GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System is indicated for thoracic, gynecologic, orthopedic, and abdominal procedures for the purpose of holding and controlling the movement of standard laparoscopes or rigid endoscopes within inflated surgical cavities during minimally invasive laparoscopic surgery.

Device Description

The GMP|Surgical Solutions Laparocision™ Scope Controller System allows for surgeons to control the movement and position of conventional laparoscopes or endoscopes during thoracic, gynecologic, orthopedic, and abdominal laparoscopic procedures by means of an electromechanical arm which is controlled by either a hand controller or a foot controller. The purpose of an endoscope is to allow visualization of a surgical cavity during minimally invasive laparoscopic procedures.

The device is comprised of the following five main components:

  1. The Laparocision™ Reusable Arm Assembly
  2. The Disposable Zoom Assembly (DZA)
  3. The Foot Control and the Hand Control
  4. The Steri-Sleeves
  5. The Power Supply
AI/ML Overview

The GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System is a device designed to assist surgeons in controlling the movement and position of laparoscopes during various minimally invasive surgical procedures.

Here's an analysis of the acceptance criteria and the study proving the device meets these criteria, based on the provided text:

1. Table of Acceptance Criteria and Reported Device Performance

Acceptance Criteria CategorySpecific Criteria/StandardReported Device Performance
Electrical Safety"UL 60601-1-UL Standard for Safety of Medical Device Equipment, Part 1: General Requirements for Safety First Edition"In-vitro electrical safety testing met all requirements of the specified standards.
"CSA C22.2 NO 601.1-M90 -Medical Electrical Equipment - Part 1: General Requirements for Safety General Instructions No 1; Supplement 1; 1994 R(1997)"In-vitro electrical safety testing met all requirements of the specified standards.
"IEC 60601-2-18 (1996-08) - Medical Electrical Equipment -- Part 2: Particular Requirements for the Safety of Endoscopic Equipment Second Edition; Amendment 1, 07-2000"In-vitro electrical safety testing met all requirements of the specified standards.
Electromagnetic Compatibility (EMC)"IEC 60601-1-2 (2001-09) - Medical Electrical Equipment Part 1-2; General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -Requirements and Tests Second Edition"In-vitro Electromagnetic Compatibility (EMC) testing met all requirements of the specified standard.
Mechanical and Functional PerformanceDevice's design and performance requirementsIn-vitro mechanical and functional testing demonstrated that the device's design and performance requirements were met. This also supported a determination of substantial equivalence to the predicate device.

2. Sample Size Used for the Test Set and Data Provenance

The provided text does not specify a sample size for a "test set" in the context of clinical trials or data analysis. The testing described is in-vitro (laboratory-based) electrical, EMC, mechanical, and functional testing of the device itself, rather than studies involving patient data or human subjects. Therefore, data provenance (country of origin, retrospective/prospective) is not applicable in this context.

3. Number of Experts Used to Establish Ground Truth for the Test Set and Qualifications of Those Experts

This information is not applicable to the provided document. The testing conducted was technical validation against engineering and safety standards, not a diagnostic or clinical performance study that would require expert-established ground truth.

4. Adjudication Method for the Test Set

This information is not applicable. The testing involved objective measurements against established technical standards, not subjective interpretations requiring adjudication.

5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done, and the Effect Size of How Much Human Readers Improve with AI vs. Without AI Assistance

This information is not applicable. The Laparocision™ Scope Controller System is an electromechanical arm for controlling an endoscope, not an AI-powered diagnostic or interpretive tool that assists human readers. Therefore, an MRMC study related to AI assistance is not relevant to this device.

6. If a Standalone (i.e., algorithm only without human-in-the-loop performance) Study Was Done

This information is not applicable. The device is a physical, electromechanical system controlled by a human operator (surgeon). It does not operate as an algorithm only. The "functional testing" performed likely evaluated its standalone mechanical and control capabilities as intended.

7. The Type of Ground Truth Used

The "ground truth" for the tests performed was established by recognized industry standards and engineering specifications. For electrical safety and EMC, the ground truth was compliance with UL, CSA, and IEC standards. For mechanical and functional testing, the ground truth was the device's design and performance requirements as defined by the manufacturer, likely benchmarked against the predicate device.

8. The Sample Size for the Training Set

This information is not applicable. The device is an electromechanical system that does not utilize a "training set" in the context of machine learning or AI algorithms. Development and validation rely on engineering design, manufacturing processes, and adherence to technical standards.

9. How the Ground Truth for the Training Set Was Established

This information is not applicable for the reasons stated above.

{0}------------------------------------------------

K050027 1/3

510(k) Summary

GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System

Classification Name: Endoscope and Accessories 21 CFR 876.1500 Device Class: II Product Code: GCJ

GMP Companies, Inc. One East Broward Boulevard Suite 1701 Fort Lauderdale, FL 33301

Phone: (954) 745-3510 Fax: (954) 745-3511

Contact: Ralph Jugo, Prepared: October 25, 2004

LEGALLY MARKETED PREDICATE DEVICE A.

The GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System is substantially equivalent to the Computer Motion Inc. AESOP System and Accessories that was cleared by FDA under K931783 on November 22, 1993.

B. DEVICE DESCRIPTION

The GMP|Surgical Solutions Laparocision™ Scope Controller System allows for surgeons to control the movement and position of conventional laparoscopes or endoscopes during thoracic, gynecologic, orthopedic, and abdominal laparoscopic procedures by means of an electromechanical arm which is controlled by either a hand controller or a foot controller. The purpose of an endoscope is to allow visualization of a surgical cavity during minimally invasive laparoscopic procedures.

The device is comprised of the following five main components:

  1. The Laparocision™ Reusable Arm Assembly is the device's main component. It is attached via a clamp to an operating table and it serves to hold and control the position and movement of a laparoscope.

  2. The Disposable Zoom Assembly (DZA) is attached to the distal end of the Reusable Arm Assembly, and its purpose is to hold 5mm and 10 mm diameter laparoscopes between its pinch rollers. The pinch rollers turn and act to move a laparoscope in three axes (i.e. in and out, towards the head or foot of the patient, and medially/laterally). The pinch rollers in the DZA are under the direct control of an operator via the Foot Control and the Hand Control.

{1}------------------------------------------------

  1. The Foot Control and the Hand Control plug into the Reusable Arm, and by pressing control buttons on the Foot and Hand Controls, the operator can move the laparoscope in three axes.

  2. The Steri-Sleeves are sterile polvethylene material bags which act to provide for protection and a sterile barrier between the reusable components (i.e. the Reusable Arm Assembly, and the Foot and Hand Controls) and the sterile field.

  3. The Power Supply converts 110 alternating current voltage (VAC) to 9 volts of direct current (9VDC) required to operate the Reusable Arm Assembly.

C. INDICATIONS FOR USE

The Laparocision™ Scope Controller System is indicated for thoracic, gynecologic, orthopedic, and abdominal procedures for the purpose of holding and controlling the movement of standard laparoscopes or rigid endoscopes within inflated surgical cavities during minimally invasive laparoscopic surgery.

D. INTENDED USE

The Laparocision™ Scope Controller System is an electromechanical arm whose intended use is to allow a surgeon to hold and control a laparoscope's movement and position during laparoscopic surgical procedures by means of either a foot controller or a hand controller.

The trade name or proprietary name of the device which is the subject of the 510(k) premarket notification is the "GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System". The common or usual name for the device is an "Endoscope Accessory".

E. SUBSTANTIAL EQUIVALENCE SUMMARY

The GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System is an electromechanical medical device that has essentially the same indications for use as the predicate device. Both devices are indicated for laparoscopic surgical procedures. The only main differences between the two devices is that the AESOP device uses a computer and software to control the devices operations, while the GMP Laparocision device does not use a computer or software to control the device's operations. The differences do not alter the intended diagnostic effect. Both devices have essentially the same intended use. A comparison of the descriptive characteristics of the GMP Laparocision device and the AESOP predicate device is sufficiently precise to assure equivalence. In-vitro performance data are provided in the form of electrical safety testing and electromagnetic compatibility (EMC) testing that was performed on both devices. The results of the performance testing demonstrate compliance with the applicable electrical safety and the data also support a determination of substantial equivalence.

{2}------------------------------------------------

As recommended by the 3-17-95 (Draft) Guidance for the Content of Premarket Notifications for Endoscopes Used in Gastroenterology and Urology, electrical safety and Electromagnetic Compatibility (EMC) testing as per the applicable standards should be conducted and provided in a 510(k) submission.

F. TECHNOLOGICAL CHARACTERISTICS

Both devices use electronic components to control the position and movement of laparoscopes during minimally invasive laparoscopic surgical procedures. While the details differ regarding how the control of the movement of laparoscopes is achieved, given that the AESOP device uses a computer and software while the GMP device does not, the basic technology is very similar. The differences in technology do not raise any significant questions or issues regarding the safety and effectiveness of the devices,

G. TESTING

In-vitro electrical safety testing was conducted and met all the requirements in accordance with the standards, "UL 60601-1-UL Standard for Safety of Medical Device Equipment, Part 1: General Requirements for Safety First Edition", CSA C22.2 NO 601.1-M90 -Medical Electrical Equipment - Part 1: General Requirements for Safety General Instructions No 1; Supplement 1; 1994 R(1997)", IEC 60601-2-18 (1996-08) - Medical Electrical Equipment -- Part 2: Particular Requirements for the Safety of Endoscopic Equipment Second Edition; Amendment 1, 07-2000".

In-vitro Electromagnetic Compatibility (EMC) testing was performed and met all the requirements as per "IEC 60601-1-2 (2001-09) - Medical Electrical Equipment Part 1-2; General Requirements for Safety - Collateral Standard: Electromagnetic Compatibility -Requirements and Tests Second Edition". In-vitro mechanical and functional testing was also performed and demonstrated that the device's design and performance requirements were met. This functional testing also demonstrates and supports a determination of substantial equivalence to the predicate device.

H. CONCLUSIONS

This pre-market notification has demonstrated Substantial Equivalence as defined and understood in Sections 513(f)(1) and 513(i)(1) of the Federal Food Drug and Cosmetic Act and various guidance documents issued by the Center for Devices and Radiological Health.

{3}------------------------------------------------

Image /page/3/Picture/1 description: The image shows the seal of the Department of Health & Human Services - USA. The seal is circular and contains the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the perimeter. In the center of the seal is an abstract image of an eagle.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

JAN 2 7 2005

GMP/Companies, Inc. c/o Mr. Daniel W. Lehtonen Intertek Testing Services 70 Codman Hill Road Boxborough, Massachusetts 01719

Re: K050027

Trade/Device Name: Laparocision Scope Controller System Regulation Number: 21 CFR 876.1500 Regulation Name: Endoscope and accessories Regulatory Class: II Product Code: GCJ Dated: January 21, 2005 Received: January 24, 2005

Dear Mr. Lehtonen:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate for asso mated in the May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FIJA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You nust comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

{4}------------------------------------------------

Page 2 -- Mr. Daniel W. Lehtonen

This letter will allow you to begin marketing your device as described in your Section 510(k) This letter will and with your finding of substantial equivalence of your device to a legally premated predicated device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please rr you desire specific arrestiance at (240) 276-0115. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.

Sincerely yours,

Muriam C. Provost

Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{5}------------------------------------------------

Indications for Use

510(k) Number (if known):

Device Name:

GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System

Indications for Use:

The GMP|Surgical Solutions Inc. Laparocision™ Scope Controller System is indicated for thoracic, gynecologic, orthopedic, and abdominal procedures for the purpose of holding and controlling the movement of standard laparoscopes or rigid endoscopes within inflated surgical cavities during minimally invasive laparoscopic surgery.

Prescription Use (Part 21 CFR 801 Subpart D) AND/OR

Over-The-Counter-Use (Part 21 CFR 801 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE JS NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Muriam C. Provost

(Division Sign-Off) Division of General, Restorative. and Neurological Devices

510(k) Number_405 0037

Posted 13 Nov 2003

Page 1 of T

§ 876.1500 Endoscope and accessories.

(a)
Identification. An endoscope and accessories is a device used to provide access, illumination, and allow observation or manipulation of body cavities, hollow organs, and canals. The device consists of various rigid or flexible instruments that are inserted into body spaces and may include an optical system for conveying an image to the user's eye and their accessories may assist in gaining access or increase the versatility and augment the capabilities of the devices. Examples of devices that are within this generic type of device include cleaning accessories for endoscopes, photographic accessories for endoscopes, nonpowered anoscopes, binolcular attachments for endoscopes, pocket battery boxes, flexible or rigid choledochoscopes, colonoscopes, diagnostic cystoscopes, cystourethroscopes, enteroscopes, esophagogastroduodenoscopes, rigid esophagoscopes, fiberoptic illuminators for endoscopes, incandescent endoscope lamps, biliary pancreatoscopes, proctoscopes, resectoscopes, nephroscopes, sigmoidoscopes, ureteroscopes, urethroscopes, endomagnetic retrievers, cytology brushes for endoscopes, and lubricating jelly for transurethral surgical instruments. This section does not apply to endoscopes that have specialized uses in other medical specialty areas and that are covered by classification regulations in other parts of the device classification regulations.(b)
Classification —(1)Class II (special controls). The device, when it is an endoscope disinfectant basin, which consists solely of a container that holds disinfectant and endoscopes and accessories; an endoscopic magnetic retriever intended for single use; sterile scissors for cystoscope intended for single use; a disposable, non-powered endoscopic grasping/cutting instrument intended for single use; a diagnostic incandescent light source; a fiberoptic photographic light source; a routine fiberoptic light source; an endoscopic sponge carrier; a xenon arc endoscope light source; an endoscope transformer; an LED light source; or a gastroenterology-urology endoscopic guidewire, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 876.9.(2) Class I for the photographic accessories for endoscope, miscellaneous bulb adapter for endoscope, binocular attachment for endoscope, eyepiece attachment for prescription lens, teaching attachment, inflation bulb, measuring device for panendoscope, photographic equipment for physiologic function monitor, special lens instrument for endoscope, smoke removal tube, rechargeable battery box, pocket battery box, bite block for endoscope, and cleaning brush for endoscope. The devices subject to this paragraph (b)(2) are exempt from the premarket notification procedures in subpart E of part 807of this chapter, subject to the limitations in § 876.9.